In gastric cancer, the notable upregulation of IL-10 and TGF-β1 family molecules plays a crucial role in forming an immunosuppressive microenvironment, offering valuable molecular insights for identifying immunotherapy targets and developing combined intervention strategies. The gene discussed is TGFB1; the disease is gastric cancer.